Ensuring the safety of hydroxyapatite involves rigorous testing and quality control during its production. Manufacturers must minimize the presence of impurities and ensure consistent particle size and phase purity. Regulatory bodies, such as the FDA, provide guidelines for the safe use of hydroxyapatite in medical devices, emphasizing the importance of biocompatibility testing and clinical trials.
